Heart rhythm safety of the mononuclear cord blood stem cells transplantation in patients with refractory ischemic heart failure

The aim – to evaluate the safety of mononuclear cord blood stem cells transplantation regarding influence upon heart rhythm in patients with refractory heart failure Materials and methods. The work is based on the analysis of Holter-ECG monitoring data in 20 patients with refractory heart failure a...

Full description

Bibliographic Details
Main Authors: O.Yu. Usenko, A.V. Yakushev, O.V. Lisun, M.V. Kostylev, V.F. Onishchenko
Format: Article
Language:English
Published: TOV Chetverta Khvylia 2016-09-01
Series:Кардіохірургія та інтервенційна кардіологія
Subjects:
Online Access:http://csic.com.ua/images/pdf/2016/3-2016/heart-rhythm-safety-mononuclear-cord-blood-stem-cells-transplantation.pdf
_version_ 1826840824146558976
author O.Yu. Usenko
A.V. Yakushev
O.V. Lisun
M.V. Kostylev
V.F. Onishchenko
author_facet O.Yu. Usenko
A.V. Yakushev
O.V. Lisun
M.V. Kostylev
V.F. Onishchenko
author_sort O.Yu. Usenko
collection DOAJ
description The aim – to evaluate the safety of mononuclear cord blood stem cells transplantation regarding influence upon heart rhythm in patients with refractory heart failure Materials and methods. The work is based on the analysis of Holter-ECG monitoring data in 20 patients with refractory heart failure and reduced myocardial contractility. With the purpose of improvement of systolic function patients underwent transplantation of mononuclear cord blood stem cells. Results. Analysis of the probable proarrhythmogenic influence of mononuclear cord blood stem cells was performed in terms of follow-up during up to 9 months. Results demonstrated that administration of the cell preparation «Cryopreserved human cord blood» is not associated with increased risk of life-threatening cardiac arrhythmias. Conclusions.Transplantation of mononuclear cord blood stem cells should not be considered as an additional arrhythmogenic risk factor in patients with refractory heart failure.
first_indexed 2024-12-12T19:15:56Z
format Article
id doaj.art-ba8b40a4f54b4290b03e15197cf78bed
institution Directory Open Access Journal
issn 2305-3127
language English
last_indexed 2025-02-16T12:48:38Z
publishDate 2016-09-01
publisher TOV Chetverta Khvylia
record_format Article
series Кардіохірургія та інтервенційна кардіологія
spelling doaj.art-ba8b40a4f54b4290b03e15197cf78bed2025-02-02T21:02:55ZengTOV Chetverta KhvyliaКардіохірургія та інтервенційна кардіологія2305-31272016-09-013 (14)1520Heart rhythm safety of the mononuclear cord blood stem cells transplantation in patients with refractory ischemic heart failureO.Yu. Usenko0A.V. Yakushev1O.V. Lisun2M.V. Kostylev3V.F. Onishchenko4O.O. Shalimov National Institute of Surgery and Transplantology of NAMS of Ukraine, Kyiv, UkraineO.O. Shalimov National Institute of Surgery and Transplantology of NAMS of Ukraine, Kyiv, UkraineO.O. Shalimov National Institute of Surgery and Transplantology of NAMS of Ukraine, Kyiv, UkraineO.O. Shalimov National Institute of Surgery and Transplantology of NAMS of Ukraine, Kyiv, UkraineO.O. Shalimov National Institute of Surgery and Transplantology of NAMS of Ukraine, Kyiv, UkraineThe aim – to evaluate the safety of mononuclear cord blood stem cells transplantation regarding influence upon heart rhythm in patients with refractory heart failure Materials and methods. The work is based on the analysis of Holter-ECG monitoring data in 20 patients with refractory heart failure and reduced myocardial contractility. With the purpose of improvement of systolic function patients underwent transplantation of mononuclear cord blood stem cells. Results. Analysis of the probable proarrhythmogenic influence of mononuclear cord blood stem cells was performed in terms of follow-up during up to 9 months. Results demonstrated that administration of the cell preparation «Cryopreserved human cord blood» is not associated with increased risk of life-threatening cardiac arrhythmias. Conclusions.Transplantation of mononuclear cord blood stem cells should not be considered as an additional arrhythmogenic risk factor in patients with refractory heart failure.http://csic.com.ua/images/pdf/2016/3-2016/heart-rhythm-safety-mononuclear-cord-blood-stem-cells-transplantation.pdfcord blood stem cellsarrhythmogenic effecttransplantationheart failure
spellingShingle O.Yu. Usenko
A.V. Yakushev
O.V. Lisun
M.V. Kostylev
V.F. Onishchenko
Heart rhythm safety of the mononuclear cord blood stem cells transplantation in patients with refractory ischemic heart failure
Кардіохірургія та інтервенційна кардіологія
cord blood stem cells
arrhythmogenic effect
transplantation
heart failure
title Heart rhythm safety of the mononuclear cord blood stem cells transplantation in patients with refractory ischemic heart failure
title_full Heart rhythm safety of the mononuclear cord blood stem cells transplantation in patients with refractory ischemic heart failure
title_fullStr Heart rhythm safety of the mononuclear cord blood stem cells transplantation in patients with refractory ischemic heart failure
title_full_unstemmed Heart rhythm safety of the mononuclear cord blood stem cells transplantation in patients with refractory ischemic heart failure
title_short Heart rhythm safety of the mononuclear cord blood stem cells transplantation in patients with refractory ischemic heart failure
title_sort heart rhythm safety of the mononuclear cord blood stem cells transplantation in patients with refractory ischemic heart failure
topic cord blood stem cells
arrhythmogenic effect
transplantation
heart failure
url http://csic.com.ua/images/pdf/2016/3-2016/heart-rhythm-safety-mononuclear-cord-blood-stem-cells-transplantation.pdf
work_keys_str_mv AT oyuusenko heartrhythmsafetyofthemononuclearcordbloodstemcellstransplantationinpatientswithrefractoryischemicheartfailure
AT avyakushev heartrhythmsafetyofthemononuclearcordbloodstemcellstransplantationinpatientswithrefractoryischemicheartfailure
AT ovlisun heartrhythmsafetyofthemononuclearcordbloodstemcellstransplantationinpatientswithrefractoryischemicheartfailure
AT mvkostylev heartrhythmsafetyofthemononuclearcordbloodstemcellstransplantationinpatientswithrefractoryischemicheartfailure
AT vfonishchenko heartrhythmsafetyofthemononuclearcordbloodstemcellstransplantationinpatientswithrefractoryischemicheartfailure